All above data revealed the enhanced metastatic abilities of the transformed cells that could be blocked by the EGFR inhibitor gefitinib, suggesting the potential preventive effects against ACC metastasis by targeting EGFR pathway. The gene discussed is EGFR; the disease is adrenal cortex carcinoma.